Complex interactions between numerous components of essential oils often contribute to the pharmacological effect and therapeutic outcome. To further elucidate these interactions, several essential oil constituents (EOCs) were combined in different ratios and their inhibitory effects on the growth of bacteria and yeast determined using the minimum inhibitory concentration (MIC) microplate assay. When combined and tested against Candida albicans, (+)-β-pinene interacted antagonistically with (-)-menthone (∑FIC T = 9.80), but synergistically with 1,8-cineole (∑FIC T = 0.35). Against Escherichia coli, the combination of E-and Z-(±)-nerolidol and geranyl acetate displayed an additive interaction (∑FIC T = 1.04); while a variable interaction was observed between E-and Z-(±)-nerolidol and eugenol with antagonism and synergy being observed at different ratios of each EOC. The combination of either carvacrol or eugenol with an antimicrobial agent (ciprofloxacin or amphotericin B) resulted in synergistic interactions against all microorganisms tested. These favourable results further support the use of essential oil constituents as adjuvants in the development of a new generation of phytopharmaceuticals that can be used in combination with synthetic drugs against drug-resistant microorganisms.
With the advent of multi-drug resistant strains compromising the successful treatment of infections, new compounds or combination regimens have become sought-after. As such, essential oils have been scientifically validated as effective anti-infective agents against a broad spectrum of microbes and warrant further research [1] [2] [3] [4] [5] [6] .
Various essential oils have been tested in combination and found to interact in variable manners. When four commercial essential oils (Melaleuca alternifolia, Mentha piperita, Rosmarinus officinalis, Thymus vulgaris) were combined with ciprofloxacin, a predominantly antagonistic interaction was noted against Staphyloccocus aureus; whilst a synergistic interaction was observed for most ratios between R. officinalis and ciprofloxacin against Klebsiella pneumoniae. When these four oils were combined with amphotericin B against Candida albicans, antagonistic interactions were mostly observed [7] . In contrast, when the oils of Origanum vulgare, Pelargonium graveolens and M. alternifolia were combined with norfloxacin and amphotericin B against Candida species, distinct synergy was noted [8, 9] . However, essential oils are complex mixtures of volatile constituents from various chemical classes with each contributing to the overall pharmacological activity of the essential oil. This activity could also be re-enforced by the various interactions that could occur between the major and/or minor constituents. To examine this possibility, selected EOCs with varying activity profiles [6] were combined and their antimicrobial properties recorded, along with interactions with standard antimicrobial agents.
Overall, synergistic interactions were observed between 8 of the 12 EOC combinations tested against three bacteria and one yeast strain; regardless of the potency of the individual EOCs (Table 1) . This can be seen by the synergistic interactions that occurred between the relatively inactive E-and Z-(±)-nerolidol and the similarly inactive γ-terpinene compared with the more potent, trans-geraniol, when tested against B. cereus, Figure 1B . Based on previous studies, the combined antimicrobial action of essential oils and their constituents are proposed to take place through two stages [5, 10] . First, there is the transfer of the terpenoid into a bioavailable form, followed by penetration into the lipid bilayer of the cytoplasmic membrane in sufficient amounts to initiate membrane disruption [10] . For Gram-negative bacteria, entry of the terpenoids into the lipid bilayer depends on the protective cellular structures, molecular size and hydrogen bonding parameters of these organisms [5] . In contrast, the antimicrobial potency against fungi and Gram-positive bacteria depends on the solubility factor. Thus, terpenoids require properties that will allow them to enter and accumulate in bioavailable forms to cause membrane disruption [10] . Figure  2A ). In contrast, the properties of E-and Z-(±)-nerolidol and eugenol resulted in variable interactions depending on the ratio of EOC used against E. coli, with either antagonism or synergy being observed. It should be noted that the ∑FIC T of 1.44 indicated antagonism for the sum of all the ratios in the combination (Table  1) . However, as seen in Figure 1C , some of the ratios were synergistic/additive as well as antagonistic. This demonstrates how crucial it is to define how the results have been interpreted and the advantage of plotting an isobologram to account for all the variations that can occur when two molecules are combined. This trend has previously been reported to occur with a 4: 1 ratio of carvacrol to thymol resulting in a synergistic effect, with the opposite effect occurring with a 1: 4 ratio [11] . Similarly, the combined efficacy of ciprofloxacin and T. vulgaris against K. pneumoniae was found to be dependent on the ratio of the two components [7] .
In contrast, all ratios in the combination between E-and Z-(±)-nerolidol and geranyl acetate against E. coli ( Figure 1C ) yielded additive interactions. Regardless of whether these two EOCs have similar or different targets, their mechanisms of action were not complementary enough to result in a synergistic interaction [12] .
The main mechanism by which terpenoids inhibit the cellular growth of microorganisms is by accumulating in the microbial cytoplasmic membrane. This increases the disorder of the bilayer with an increased ratio of saturated fatty acid to unsaturated fatty acid, decreased membrane potential and pH gradient, with an increased efflux of small ions such as K + . Once the osmotic balance of the microbial cell is disturbed, the microbial ATP energy stores become depleted [5, 10, 13, 14] . The compromised microbial structural integrity has a detrimental effect on the cytoplasm and nuclear material, eventually leading to cell death [12] .
Although the ideal interaction between any two compounds is one of synergy, it is however important to note that the activity of two active EOCs can be compromised when combined. This was observed with the antagonistic interaction (∑FIC T = 9.80) between the ketone, (-)-menthone, and monoterpene, (+)-β-pinene against C. albicans (Table 1; Figure 2B) . The mechanism by which β-pinene elicits its antimicrobial properties in Saccharomyces cerevisiae was by selectively inhibiting mitochondrial respiration localized to the cytochrome b region of the electron transport chain, with resultant increased fluidity and disturbances of the mitochondrial membrane [15] . A similar mechanism of action was reported for α-pinene on the mitochondrial respiration and membrane integrity of maize seedlings [16] . However, this potent mechanism of action was antagonized upon the addition of (-)-menthone ( Figure 2B ). Other than the mechanism by which most terpenes act on bacteria, it has been reported that (-)-menthone also inhibits the mitochondrial electron transfer chain in plant respiration [17] . Thus, it is possible that although both EOCs are highly potent if used individually, when combined their similar mechanism of actions compete and antagonise each other's inhibitory effects. where the mechanism of action of the EOCs were proposed to involve a primary lesion of the cell membrane in preference to metabolic impairment as the cause of microbial death [18] .
Potential interactions of EOCs with antibiotics are another area where essential oils hold great promise. In an age of increasing microbial resistance to drugs, there is a trend to look for ways to minimise the development of resistance to existing drugs instead of seeking new antibiotics to overcome resistance. A benefit of using an essential oil is that due to the chemical complexity of the combination, the chance of developing resistance is significantly reduced. It was reported that the combination of chloramphenicol and essential oils from Korean aromatic plants were effective in a synergistic manner against S. aureus [19] . Similarly, a 43% potentiation of the activity of gentamicin was demonstrated following the addition of the essential oil of Croton zehntneri [20] . However, the toxicity profile of a single EOC is easier to control and it has been reported that adverse effects such as skin irritation are absent or minimal when applied topically [21] .
In order to examine the interaction between a potent EOC and standard antimicrobial agent on Gram-positive, Gram-negative and yeast species, either carvacrol or eugenol were combined with either ciprofloxacin or amphotericin B (Table 2) . For all combinations, regardless of the microbe used, a synergistic interaction was observed (Table 2; Figure 3 ). In addition, when the inactive eugenol (MIC>194.9 mM) was combined with ciprofloxacin (MIC=0.00075 mM) against S. aureus, a synergistic interaction (∑FIC T = 0.35) was also observed. It is thus possible that the EOC increases membrane permeability, allowing for the increased accumulation of ciprofloxacin to inhibit bacterial topoisomerase II and IV and thereby inhibit DNA synthesis [13, 22] .
The synergistic interaction between the two amphipathic agents, namely the antifungal, amphotericin B and the phenolic EOC, carvacrol ( Figure 3B) , is a favorable one to eliminate candidiasis, a frequently occurring opportunistic infection. This interaction indicates that the administered dose of both agents could be reduced to elicit an effective therapy with fewer adverse effects. Both molecules interfere with the integrity of the cell membrane, with amphotericin B binding selectively to ergosterol, forming transmembrane pores which allow for the leakage of intracellular ions and macromolecules [23] .
This eventually leads to cell death, which would be enhanced by the concurrent administration of carvacrol. Thymol has also been reported to potentiate the antifungal activity of amphotericin B, where it was shown to interfere with the morphology of the yeast envelope decreasing the virulence of the pathogen to colonise host tissues and its pathogenicity [24] .
To eradicate a drug-resistant infection, the therapy should ideally be composed of two complementary agents that can enhance each other's mechanism of action. However, one should be aware that not only is there resistance to standard antimicrobial agents, but it has been reported that B. cereus developed resistance to sub-lethal doses of carvacrol by altering the fatty acid ratio and composition, which increased membrane fluidity [13, 25] . In addition, resistance adaptations were observed in methicillin-resistant S. aureus when sublethal concentrations of tea tree oil (M. alternifolia) were incubated with various antibiotics such as chloramphenicol, trimethoprim and mupirocin [26] .
In conclusion, the combination of two EOCs in varying ratios produced synergistic, additive and antagonistic interactions. However, the mechanism of action of these interactions is not yet fully understood, and warrants further detailed investigation. The results of this study show that EOCs in combination have the ability to potentiate each other's mechanisms of action, and can be advantageous when treating microorganisms resistant to standard antimicrobial agents. However, the dosage and route of administration of the EOC together with a standard antimicrobial agent still require further research to support their credibility as a plausible therapeutic combination to eradicate resistant infectious microorganisms.
Experimental
Essential oil constituents: Select essential oil constituents were purchased from Sigma-Aldrich and the purity and percentage composition verified to the supplier's specifications by gas chromatography (minimum purity ≥95%). [27] .
In order to evaluate the interaction between EOCs with variable activity, 16 combinations were evaluated [6] . Combination ratios were prepared from the stock solutions (128 mg/mL in acetone) of the EOCs and controls. Nine fixed ratios of either the two EOCs or EOC and control antimicrobial drug (ciprofloxacin or amphotericin B) were combined as follows: 10:90; 20:80; 30:70; 40:60; 50:50; 60:40; 70:30; 80:20; 90:10 (v/v) and from each ratio, a further 8 serial dilutions were prepared in a 96 well microtitre plate. Following the addition of the microbial inocula, the plates were incubated at 37°C for 24 h for the bacteria and 48 h for the yeast. At this time, 50 µM p-iodonitrotetrazolium violet was added to the bacteria and yeast microtitre plates and left at ambient temperature for either 6 h or 24 h, respectively. The lowest concentration having no color change was defined as the MIC [27] . Each combination was replicated at least twice to confirm consistency.
Data analysis:
The MIC value of each ratio was determined and the type of interaction classified in two ways, namely from an isobologram and by determining the total ∑FIC value for all 9 ratios in each combination (∑FIC T ) [28] . The data points for construction of the isobolograms were obtained for the various ratios by plotting the MIC of the two EOCs in combination divided by the MIC of the first EOC when used alone (on the X-axis) versus the MIC of the two EOCs in combination divided by the MIC of the second EOC when used alone (on the Y-axis). Values on the isobologram lying above the line were interpreted as being antagonistic, below as synergistic and those on or near the line as additive. It must be noted that there may be some points on the isobolograms overlying each other and sometimes cannot be clearly seen. Secondly, to verify the interaction read from the isobologram, the total ∑FIC for all 9 ratios was calculated for each combination. These ∑FIC T values were interpreted as follows: <1 as synergistic, >1.0 as antagonistic and a value of 1 as additive [28] .
